Abstract:Catechols initially engage with the N‐terminus and non‐amyloid‐β component (NAC) region of α‐synuclein through noncovalent interactions in a dose‐dependent manner. Over time, likely due to their close proximity and inherent chemical properties, these interactions turn into a covalent bond involving lysine residues, contributing to inhibit α‐synuclein fibril formation. Parkinson's disease (PD) stands as a challenging neurodegenerative condition characterized by the emergence of Lewy Bodies (LBs), intracellular inclusions within dopaminergic neurons. These LBs harbor various proteins, prominently including α‐Synuclein (Syn) aggregates, implicated in disease pathology. A promising avenue in PD treatment involves targeting Syn aggregation. Recent findings from our research have shown that 3,4‐dihydroxyphenylacetic acid (DOPAC) and 3,4‐dihydroxyphenylethanol (DOPET) possess the ability to impede the formation of Syn fibrils by disrupting the aggregation process. Notably, these compounds primarily engage in noncovalent interactions with the protein, leading to the formation of off‐pathway oligomers that deter fibril growth. Through proteolysis studies and mass spectrometry (MS) analysis, we have identified potential covalent modifications of Syn in the presence of DOPAC, although the exact site remains elusive. Employing molecular dynamics simulations, we delved into how DOPAC‐induced covalent alterations might affect the mechanism of Syn aggregation. Our findings indicate that the addition of a covalent adduct on certain residues enhances fibril flexibility without compromising its secondary structure stability. Furthermore, in the monomeric state, the modified residue fosters novel bonding interactions, thereby influencing long‐range interactions between the N‐ and C‐termini of the protein.

Revisiting the role of 3-nitrotyrosine residues in the formation of alpha-synuclein oligomers and fibrils

Insights Into the Mechanism of Tyrosine Nitration in Preventing -Amyloid Aggregation in Alzheimer's Disease

Insights Into the Mechanism of Tyrosine Nitration in Preventing β-Amyloid Aggregation in Alzheimer’s Disease

A targetable N-terminal motif orchestrates α-Synuclein oligomer to fibril conversion

Alpha-Synuclein Nitration and Its Implications in Parkinson's Disease.

Nitration of Tyrosine Residue Y10 of Aβ1-42 Significantly Inhibits Its Aggregation and Cytotoxicity.

Red-Light-Photosensitized Tyrosine 10 Nitration of β-Amyloid1-42 Diverts the Protein from Forming Toxic Aggregates

Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation.

The influence of N-terminal acetylation on micelle-induced conformational changes and aggregation of α-Synuclein

Molecular characterization of an aggregation-prone variant of alpha-synuclein used to model synucleinopathies

Distinct Region-Specific Α-Synuclein Oligomers in A53T Transgenic Mice: Implications for Neurodegeneration

Early expression of monomeric and oligomeric alpha-synuclein and reduction of tyrosine hydroxylase following intranigral injection of lipopolysaccharide

Understanding the Modulation of α-Synuclein Fibrillation by N -Acetyl Aspartate: A Brain Metabolite

Catechol‐induced covalent modifications modulate the aggregation tendency of α‐synuclein: An in‐solution and in‐silico study

Characterization of the Non-Fibrillar alpha-Synuclein Oligomers

Elucidating the Role of C-terminal Post-Translational Modifications Using Protein Semisynthesis Strategies: Α-Synuclein Phosphorylation at Tyrosine 125.

Immunocytochemical study on the distribution of nitrotyrosine in the brain of the transgenic mice expressing a human Cu/Zn SOD mutation

Altered Conformation of Α-Synuclein Drives Dysfunction of Synaptic Vesicles in a Synaptosomal Model of Parkinson's Disease.

Post-translational Modification of α-Synuclein Modifies Monomer Dynamics and Aggregation Kinetics

Conversion of Natively Unstructured Α-Synuclein to Its Α-Helical Conformation Significantly Attenuates Production of Reactive Oxygen Species.

Conformational equilibria in monomeric alpha-synuclein at the single molecule level